GHATNEKAR, Ola; HJALTE, Frida; TAYLOR, Matthew. Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib – a Swedish model application. Acta Oncologica, [S. l.], v. 49, n. 6, p. 851–858, 2010. DOI: 10.3109/0284186X.2010.495132. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/32708. Acesso em: 21 feb. 2025.